Pivadga, C. et al. 2026. Hydroxyurea Dose Escalation to Maximum Tolerated Dose in Pediatric Sickle Cell Disease: Hematologic and Clinical Outcomes in a Resource-Limited Setting in Cameroon. A Quasi-Experimental Study. Student’s Journal of Health Research Africa. 7, 3 (Mar. 2026), 10. DOI:https://doi.org/10.51168/6zd3jy11.